EUVIMEDEUVIMED entdecken
Open Access

Targeting the ARL4C/RAP1/PI3K-Akt-mTOR signaling loop promotes ARL4C ubiquitination and reverses oxaliplatin resistance in colorectal cancer

Yang Wang, Zewen Chang, Ziquan Sun, Lu Wang, Jingtao Li, Guodong Li, Yuliuming Wang, Jinning Zhang, Lianjie Ai, Zhongxu Zhang, Jiaojiao Dong, Ming Liu

Theranostics · 01.01.2026 · 16 (1) · 99-122

DOI: 10.7150/thno.117590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 01.01.2026. Verfasst von Yang Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal Oncology Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Oxaliplatin, Drug Resistance, Neoplasm, ADP-Ribosylation Factors. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsOxaliplatinDrug Resistance, NeoplasmADP-Ribosylation FactorsHumansAnimalsSignal TransductionMiceTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktUbiquitinationCell Line, TumorPhosphatidylinositol 3-KinasesAntineoplastic AgentsEpithelial-Mesenchymal TransitionMolecular Docking SimulationMice, Inbred BALB CXenograft Model Antitumor AssaysFemaleMice, NudeNaphthoquinonesMaleApoptosis

Stichwörter der Autor:innen

ARL4Ccolorectal canceroxaliplatinubiquitinationβ-Lapachone

Substanzen

OxaliplatinADP-Ribosylation FactorsTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktARL4C protein, humanPhosphatidylinositol 3-KinasesMTOR protein, humanAntineoplastic AgentsNaphthoquinones

Autor:innen und Institutionen

  • Colorectal Oncology Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Heilongjiang Province Key Laboratory of Digestive Surgery and Nutrition & Metabolism, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
  • Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.

Zitieren

APA

Wang, Y., Chang, Z., Sun, Z., Wang, L., Li, J., Li, G., Wang, Y., Zhang, J., Ai, L., Zhang, Z., Dong, J., & Liu, M. (2026). Targeting the ARL4C/RAP1/PI3K-Akt-mTOR signaling loop promotes ARL4C ubiquitination and reverses oxaliplatin resistance in colorectal cancer. Theranostics, 16(1), 99-122. https://doi.org/10.7150/thno.117590

Vancouver

Wang Y, Chang Z, Sun Z, Wang L, Li J, Li G, et al. Targeting the ARL4C/RAP1/PI3K-Akt-mTOR signaling loop promotes ARL4C ubiquitination and reverses oxaliplatin resistance in colorectal cancer. Theranostics. 2026;16(1):99-122. doi:10.7150/thno.117590

BibTeX
@article{Wang2026,
  author = {Wang, Yang and Chang, Zewen and Sun, Ziquan and Wang, Lu and Li, Jingtao and Li, Guodong and Wang, Yuliuming and Zhang, Jinning and Ai, Lianjie and Zhang, Zhongxu and Dong, Jiaojiao and Liu, Ming},
  title = {Targeting the ARL4C/RAP1/PI3K-Akt-mTOR signaling loop promotes ARL4C ubiquitination and reverses oxaliplatin resistance in colorectal cancer},
  journal = {Theranostics},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {99--122},
  doi = {10.7150/thno.117590}
}
Kostenlos starten →